Oxford Nanopore Technologies 

€2.74
108
-€0.10-3.59% 07:01 Today

Statistics

Day High
0
Day Low
0
52W High
2.84
52W Low
1.232
Volume
0
Avg. Volume
109
Mkt Cap
2.67B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Aug 19Expected
Q4 2025
Q2 2026
-0.08
-0.07
-0.06
-0.06
Expected EPS
-0.07604558935450201
Actual EPS
-0.055642837194

Financials

-64.87%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
258.61MRevenue
-167.77MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4R0.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina offers sequencing and array-based solutions for genetic and genomic analysis, competing directly in the DNA sequencing market.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences provides long-read sequencing technologies, directly competing with Oxford Nanopore's long-read sequencing capabilities.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific offers a range of sequencing solutions and genetic analysis tools, competing in the broader genomics and molecular diagnostics market.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products, including droplet digital PCR systems, which compete in the genomics space.
Qiagen NV
QGEN
Mkt Cap10.37B
Qiagen offers sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the nucleic acid technology market.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG, through its acquisition of GenMark Diagnostics, competes in the next-generation sequencing and molecular diagnostics market.
Agilon Health
AGL
Mkt Cap1.43B
Agilent Technologies provides instruments, services, consumables, applications, and expertise, competing in the life sciences and applied chemical markets for genomics and molecular diagnostics.
Bionano Genomics
BNGO
Mkt Cap16.07M
Bionano Genomics offers the Saphyr system for genome analysis, competing in the structural variation detection and genome mapping space.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genomic and molecular diagnostics markets with a focus on next-generation sequencing.

About

Oxford Nanopore Technologies plc is dedicated to the development and commercialization of an innovative technology platform. This platform leverages nanopore-based sensing to facilitate the analysis of various types of molecules. The company's product line includes several key devices: The MinION, a portable unit designed for sequencing deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The GridION, a self-contained benchtop instrument capable of operating and analyzing up to five MinION or Flongle flow cells. The MinION Mk1C, which integrates basecalling and data analysis, featuring a touchscreen interface and wireless connectivity. Flongle, an adapter that allows the use of Flongle flow cells with MinION or GridION devices. The GridION Mk1, another benchtop nanopore sequencer offered by the company. The PromethION 2 Solo and PromethION 2, providing an economical gateway to high-yield PromethION sequencing. Larger-scale needs are addressed by the PromethION 24 and PromethION 48 benchtop nanopore sequencers, which cater to multiple users for multi-sample and multi-experiment sequencing. VolTRAX, a USB-powered device that automates laboratory preparation steps prior to nanopore sequencing. In addition to hardware, Oxford Nanopore offers a suite of software solutions: MinKNOW, a software application for data acquisition, real-time analysis with feedback, local basecalling, and data streaming. Specialized Basecalling tools for identifying the sequence and type of bases in DNA/RNA molecules. EPI2ME, a cloud-based platform for comprehensive, real-time analysis of nanopore data. EPI2ME Labs, a bioinformatics resource designed to help users enhance their expertise and confidence in analyzing nanopore-based sequencing data. The company is also actively developing new products, including the MinION Mk1D, Ubi, Plongle, and SmidgION. Its products are available for purchase online. Established in 2005, the company was initially known as Oxford NanoLabs Limited before changing its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc maintains its headquarters in Oxford, United Kingdom.
Show More
CEO
Francis Albert Luc Van Parys
Employees
1314
Country
United Kingdom
ISIN
GB00BP6S8Z30
WKN
000A3C307

Listings

0 Comments

Share your thoughts

FAQs

What is Oxford Nanopore Technologies stock price today?▼
The current price of 4R0.MU is €2.74 EUR — it has decreased by -3.59% in the past 24 hours. Watch Oxford Nanopore Technologies stock price performance more closely on the chart.
What is Oxford Nanopore Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Oxford Nanopore Technologies stocks are traded under the ticker 4R0.MU.
Is Oxford Nanopore Technologies stock price growing?▼
4R0.MU stock has risen by +7.12% compared to the previous week, the month change is a +9.52% rise, over the last year Oxford Nanopore Technologies has showed a +76.65% increase.
What is Oxford Nanopore Technologies market cap?▼
Today Oxford Nanopore Technologies has the market capitalization of 2.67B
When is the next Oxford Nanopore Technologies earnings date?▼
Oxford Nanopore Technologies is going to release the next earnings report on March 9, 2027.
What were Oxford Nanopore Technologies earnings last quarter?▼
4R0.MU earnings for the last quarter are -0.06 EUR per share, whereas the estimation was -0.08 EUR resulting in a +26.83% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Oxford Nanopore Technologies revenue for the last year?▼
Oxford Nanopore Technologies revenue for the last year amounts to 258.61M EUR.
What is Oxford Nanopore Technologies net income for the last year?▼
4R0.MU net income for the last year is -167.77M EUR.
How many employees does Oxford Nanopore Technologies have?▼
As of November 2, 2026, the company has 1,314 employees.
In which sector is Oxford Nanopore Technologies located?▼
Oxford Nanopore Technologies operates in the Health & Wellness sector.
When did Oxford Nanopore Technologies complete a stock split?▼
Oxford Nanopore Technologies has not had any recent stock splits.
Where is Oxford Nanopore Technologies headquartered?▼
Oxford Nanopore Technologies is headquartered in Oxford, United Kingdom.